Barely Significant
← all excerpts

Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid.

Pharmacogenomics J · 2020 · PMC6800829 · PMID 30992538

Europe PMCDOI
1
hedged sentence
0.1670
closest p · 3.3× alpha
0.1670
boldest claim

The sentences

did not reach statistical significancep=0.167not close (p > 0.1)
SNPs for both rs4149117 and rs7311358 were more common in the azathioprine group than in the mycophenolate group, but this did not reach statistical significance (rs 7311358: 33.3% vs. 24.5%, p=0.167; rs4149117: 33.3% vs. 24.8%, p=0.235) Survival The primary outcome of one-year survival was significantly decreased in Mycophenolate patients carrying at least one copy of the SNP in both rs4149117 (334TT/TG, Figure 3A , p=0.040) and rs7311358 (699GG/GA, figure 3B , p=0.030).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.